The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksS & U Regulatory News (SUS)

Share Price Information for S & U (SUS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,990.00
Bid: 1,980.00
Ask: 2,000.00
Change: 0.00 (0.00%)
Spread: 20.00 (1.01%)
Open: 1,990.00
High: 0.00
Low: 0.00
Prev. Close: 1,990.00
SUS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

9 Feb 2018 07:00

RNS Number : 3799E
S & U PLC
09 February 2018
 

 9th February 2018

 

S&U plc

("S&U" or "the Group")

 

YEAR END TRADING UPDATE

 

S&U plc, the motor finance and property bridging lender, today issues a trading update for the period from its trading statement of 7 December 2017 to the Group's year-end on 31 January 2018.

 

Group trading remains strong and in line with expectations; demand for Advantage's motor finance has seen a record 24,500 transactions in the year, defying recent reports of a slowing car market. Aspen Bridging has lent over £10m and early repayments are in line with expectations. S&U's final results will be announced on 27 March 2018.

 

Advantage Finance

Our record-breaking motor finance business continues to do precisely that. Customer numbers have reached 54,000 against 43,000 a year ago and new transactions exceeded last year by 22% at 24,500, reflecting strong demand for our products. We continue to further refine our underwriting, underpinning future debt quality and resulting in even tighter approval rates.

 

Whilst this has led to improvements in initial customer quality scores, Advantage's new industry leading Dealflo system, fully rolled out in the period, has led to a significant improvement in transaction-to-approval rates. We expect this in turn to lead to further growth in high quality business, margin improvement and a gradual reversal in the recent, and historically small, uptick in impairment-to-revenue.

 

Furthermore, early signs are that the recent fall in new car sales is likely to buttress used car values, whilst the economic advantages of diesel vehicles remain widely appreciated in Advantage's non-prime sector of the market.

 

Aspen Bridging

Aspen, our Solihull based, property bridging pilot continues to justify its launch last year. Over £10m of loans have now been issued, many into the buoyant residential refurbishment market for starter family housing. Costs have been controlled and lending margins and LTVs maintained to budget. We have already seen a number of repayments come through and we are increasingly confident in the long-term viability and prospects for this business.

 

IFRS9

From 1 February 2018 and for our accounts for the forthcoming year ending 31 January 2019, IFRS9 "Financial Instruments" replaces IAS 39 for the way we value and measure our financial assets. In particular, IFRS9 requires the impairment of our customer receivables to be recognised through an expected loss model rather than IAS 39's emphasis on historical impairment triggers. Good progress has been made on the new methodology and its effect on our accounting policies and receivable values. For illustration, the estimated impact of IFRS9 would have been a reduction of reported receivables by between 0.5% and 2.5% as at January 2017. As this is an accounting adjustment, there is no impact on either the Group's cash flows or on the underlying profitability of its loans.

 

Treasury

A healthy market and our confidence in lending quality has seen combined investment in Advantage and Aspen this year reach a record £53m. As a result, Group borrowings are now at £105m and, although this rate of investment is expected to slow next year, we expect further funding facilities to be concluded shortly which will bring total committed facilities to £135m. This will provide sensible headroom for growth whilst maintaining gearing at S&U's historically conservative levels.

 

Dividend

The Group's profit performance and prospects have led the Board to approve a second interim dividend this year of 32p per ordinary share (2016: 28p). This will be payable on 16 March 2018 to shareholders on the share register on 23 February 2018. This means that our first two dividends this year, including the 28p per share paid in November, will total 60p against 52p a year ago, 43p in 2016 and 36p three years ago. These measures are consistent with our aim of returning to twice covered dividends in the near future.

 

Commenting on the Group trading and outlook, Anthony Coombs, Chairman of S&U said:

"Whilst the political and economic uncertainties inherent in both the Brexit negotiations and a slowing economy remain, S&U continues to demonstrate its historic ability to produce excellent results and strong, sustainable growth. We are confident that will continue."

 

Our preliminary results for the year ended 31 January 2018 will be announced on 27 March 2018.

For further information, please contact:

 

S&U plc www.suplc.co.uk 

Anthony Coombs, Chairman 0121 705 7777

 

Peel Hunt

Adrian Trimmings/Rishi Shah 020 7418 8900

 

Media and Investor Relations - Smithfield

Ged Brumby 020 3047 2527

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBRGDDLDGBGII
Date   Source Headline
3rd May 20245:49 pmRNSDirector/PDMR and PCA Shareholding
3rd May 20242:00 pmRNSAnnual Report and Accounts
1st May 20244:19 pmRNSDirector/PDMR and PCA Shareholding
9th Apr 20247:00 amRNSPreliminary Unaudited FY Results to 31 Jan 24
25th Mar 20247:00 amRNSResults Presentations for Analysts and Investors
9th Feb 20247:00 amRNSTrading Statement and Notice of Results
1st Feb 20242:30 pmRNSNotice of Trading Update
11th Jan 20242:00 pmRNSDirector/PDMR Shareholding
12th Dec 20237:00 amRNSTrading Statement to 11 December 2023
31st Oct 20232:29 pmRNSDirector/PDMR and PCA Shareholding
5th Oct 20237:00 amRNSDirectorate Change
3rd Oct 20237:00 amRNSInterim Results for the 6 months to 31 July 2023
4th Sep 20237:00 amRNSNotice of Results and Investor Presentation
10th Aug 20237:00 amRNSTrading Update and Notice of Results
25th Jul 202311:34 amRNSDirector/PDMR Shareholding
17th Jul 20233:34 pmRNSDirector/PDMR Shareholding
26th May 20234:38 pmRNSDirector/PDMR Shareholding
25th May 202312:43 pmRNSResult of AGM
25th May 20237:00 amRNSAGM Statement and Trading Update
25th Apr 20232:00 pmRNSAnnual Report and Accounts
25th Apr 202311:48 amRNSDirector/PDMR Shareholding
20th Apr 20237:00 amRNSMello Investor Presentation
6th Apr 20234:08 pmRNSAnnouncement of Annual Report and Accounts
28th Mar 20234:35 pmRNSPrice Monitoring Extension
28th Mar 20237:00 amRNSPreliminary Results
23rd Mar 20234:35 pmRNSPrice Monitoring Extension
28th Feb 20237:00 amRNSResults Presentations for Analysts and Investors
14th Feb 20232:00 pmRNSAppointment of Executive Director
9th Feb 20237:00 amRNSTrading Statement and Notice of Results
8th Dec 20227:00 amRNSTrading Statement
27th Sep 20227:00 amRNSInterim Results
30th Aug 20227:00 amRNSResults Presentations for Analysts and Investors
18th Aug 20224:36 pmRNSPrice Monitoring Extension
10th Aug 20227:00 amRNSTrading Update and Notice of Results
3rd Aug 20224:40 pmRNSSecond Price Monitoring Extn
3rd Aug 20224:35 pmRNSPrice Monitoring Extension
8th Jul 20225:06 pmRNSDirector/PDMR and PCA Shareholding
1st Jun 20227:00 amRNSTotal Voting Rights
26th May 202212:33 pmRNSResult of AGM
26th May 20227:00 amRNSAGM Statement and Trading Update
23rd May 20227:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
18th May 202211:30 amRNSOptions, Director/PDMR Shareholding, Voting Rights
13th May 20224:33 pmRNSDirector/PDMR Shareholding
5th May 20221:53 pmRNSDirector/PDMR Shareholding, Options, Voting Rights
26th Apr 20222:00 pmRNSAnnual Report and Accounts
4th Apr 20227:00 amEQSEdison Investment Research Limited: S&U (SUS): Seeing recovery and adapting to grow
4th Apr 20227:00 amRNSAnnual Report and Accounts
29th Mar 20227:00 amRNSPreliminary Results
9th Mar 20227:00 amRNSResults Presentations for Analysts and Investors
10th Feb 20227:00 amRNSTrading Statement and Notice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.